pseudoephedrine hydrochloride 6 MG/ML / triprolidine hydrochloride 0.25 MG/ML Oral Solution
- RxCUI
- 1099308
- RxNorm name
- pseudoephedrine hydrochloride 6 MG/ML / triprolidine hydrochloride 0.25 MG/ML Oral Solution
- Display name
- Pseudoephedrine/Triprolidine (Oral Liquid)
- Full name
- pseudoephedrine hydrochloride 6 MG/ML / triprolidine hydrochloride 0.25 MG/ML Oral Solution
- Term type
- SCD
- Status
- Active
- Strength
- 30-1.25 mg/5ml
- Dose form
- Sol
- Route
- Oral Liquid
- Updated
- 2026-07-27 06:53:52
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 052011
- Active start
- 052011
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
RxNav current and historical NDC rows page 2 of 2 · 123 matching rows.
NDC11, Source, Active table| NDC11 | Source | Active |
|---|
| 59741013720 | rxnav_historical | |
| 60432060004 | rxnav_historical_indirect | |
| 60432060008 | rxnav_historical | |
UNII Substances#
UNII substance links page 1 of 1 · 0 matching rows.
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|
| 132fff99-f8fa-4cc5-9cd1-c39a048511b5 | pseudoephedrine HCl 30 MG / triprolidine HCl 1.25 MG in 5 mL Oral Solution [PSN] · pseudoephedrine hydrochloride 6 MG/ML / triprolidine hydrochloride 0.25 MG/ML Oral Solution [SCD] · pseudoephedrine hydrochloride 30 MG / triprolidine hydrochloride 1.25 MG per 5 ML Oral Solution [SY] | 3 | 1 | Maxi-Tuss TR | 20200623 |
Recently Linked DailyMed Labels#
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | R06AX | Other antihistamines for systemic use | ATC1-4 | | triprolidine |
| ATC | R01BA | Sympathomimetics | ATC1-4 | | pseudoephedrine |
| FDASPL | N0000175552 | alpha-Adrenergic Agonist | EPC | has_epc | pseudoephedrine |
| MEDRT | D054199 | Pseudoephedrine | CHEM | has_ingredient | pseudoephedrine |
| MEDRT | D054199 | Pseudoephedrine | CHEM | has_ingredient | pseudoephedrine hydrochloride |
| MEDRT | D014311 | Triprolidine | CHEM | has_ingredient | triprolidine hydrochloride |
| MEDRT | D014311 | Triprolidine | CHEM | has_ingredient | triprolidine |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D003233 | Conjunctivitis, Allergic | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D003233 | Conjunctivitis, Allergic | DISEASE | may_treat | triprolidine |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | triprolidine hydrochloride |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | triprolidine |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | triprolidine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pseudoephedrine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pseudoephedrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | triprolidine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | triprolidine hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | triprolidine hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | triprolidine |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | pseudoephedrine |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | pseudoephedrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | pseudoephedrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | pseudoephedrine |
| MEDRT | N0000000245 | Adrenergic beta-Agonists | MOA | has_moa | pseudoephedrine |
| MEDRT | N0000000245 | Adrenergic beta-Agonists | MOA | has_moa | pseudoephedrine hydrochloride |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | triprolidine hydrochloride |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | triprolidine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | triprolidine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | pseudoephedrine |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | triprolidine hydrochloride |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | pseudoephedrine hydrochloride |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | pseudoephedrine hydrochloride |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | pseudoephedrine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | triprolidine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | triprolidine hydrochloride |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | pseudoephedrine |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | pseudoephedrine hydrochloride |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 6 MG/ML / 0.25 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | SNOMEDCT | 1303249006 |
| CODES | VUID | 4005158 |
| CODES | VUID | 4005163 |
| NAMES | Prescribable Synonym | pseudoephedrine HCl 30 MG / triprolidine HCl 1.25 MG in 5 mL Oral Solution |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |